id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0106-0004,FDA,FDA-2000-N-0106,Supporting Statement Good Laboratory Practices (GLP) for Non-Clinical Laboratory Studies 21 CFR Part 58 OMB #0910-0119,Supporting & Related Material,Statement (Supporting and Related Material),2017-05-09T04:00:00Z,2017,5,,,2017-05-09T18:35:31Z,,0,0,090000648259db43
FDA-2000-N-0106-0003,FDA,FDA-2000-N-0106,Agency Information Collection Activities; Announcement of OMB Approval; Application for Exemption From Federal Preemption of State and Local Medical Device Requirement,Notice,Notice of Approval,2000-06-01T04:00:00Z,2000,6,2000-06-01T04:00:00Z,,2025-04-07T13:52:24Z,00-13742,0,0,09000064804c2564
FDA-2000-N-0106-0002,FDA,FDA-2000-N-0106,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Application for Exemption From Federal Preemption of State and Local Medical Device Requirements,Notice,60 Day Proposed Information Collection,2000-04-18T04:00:00Z,2000,4,2000-04-13T04:00:00Z,2000-05-16T03:59:59Z,2025-04-07T13:52:24Z,00-9132,0,0,09000064804c255b
FDA-2000-N-0106-0001,FDA,FDA-2000-N-0106,Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Exemption From Federal Preemption of State and Local Medical Device Requirement,Notice,60 Day Proposed Information Collection,2000-01-24T05:00:00Z,2000,1,2000-01-18T05:00:00Z,2000-03-21T04:59:59Z,2025-04-07T13:52:23Z,00-992,0,0,09000064804c253c